Nanhua Bio-Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
April 28, 2021 at 04:46 am EDT
Share
NanHua Bio-medicine Co. Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 33.131 million compared to CNY 18.507 million a year ago. Operating income was CNY 2.268 million compared to operating loss of CNY 843,409.34 a year ago. Net income was CNY 957,093.09 compared to net loss of CNY 1.600 million a year ago. Basic earnings per share from continuing operations was CNY 0.0031 compared to basic loss per share from continuing operations of CNY 0.005 a year ago.
Landfar Bio medicine Co Ltd is a China-based company mainly engaged in the biomedical and energy conservation & environmental protection business. The Companyâs biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Companyâs energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The Company is involved in other businesses related to aid and build project. The Company mainly conducts businesses within the domestic market.
LANDFAR BIO-MEDICINE CO., LTD 
